Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 15, 2026
Accession Number:
0001493152-26-016154
Submission Type:
POS AM
CIK:
0001541157
Company Name:
Akari Therapeutics Plc
File Number:
333-292930